Business
Siemens Healthineers : Cercare Medical and Siemens Healthineers today announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion (CBCT-P) in acute stroke care and leverage its capability to show the flow of blood through the brain’s tissue and visualize how well different areas are being supplied with oxygen and nutrients.
Siemens Healthineers : Cercare Medical and Siemens Healthineers today announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion
About this update from Siemens Healthineers Ag
[{"type":"text","content":"\n Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patients \n Collaboration supports the vision of angio-only approach for precise and timely stroke care \n Method supports immediate assessment of tissue viability during and after thrombectomy to detect complications \n \n Cercare Medical and Siemens Healthineers today announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion (CBCT-P) in acute stroke care and leverage its capability to show the flow of blood through the brain's tissue and visualize how well different areas are being supplied with oxygen and nutrients. The joint solution combines the Cercare Medical Neurosuite (CMN), an integrated portfolio of advanced, vendor-neutral imaging software solutions that deliver automated perfusion analysis across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Cone-Beam CT with the Siemens Healthineers Syngo DynaCT Multiphase, a 3D acquisition protocol that enables up to ten CBCT angiography phases. The two solutions combined enable advanced perfusion and metabolic imaging directly in the angiography suite, helping clinicians diagnose stroke and during intervention reducing the need of transferring the patient from the angiography room to the imaging modality. This capability has the potential to streamline workflows and shorten the time to treatment, which is a critical factor for the outcome of stroke patients. \n \n \n Stroke remains one of the leading causes of death and long term disability worldwide, with one in four adults expected to experience a stroke in their lifetime1. Because millions of neurons are lost each minute, rapid and accurate imaging is essential to guide treatment decisions. The solution supports immediate assessment of tissue viability during and after thrombectomy - including detection of distal occlusions, microvascular disturbances, and the no-reflow phenomenon. Cone-Beam CT Perfusion delivers near CT-like perfusion maps on angiography systems, providing clinicians with intra-procedural insight into both conventional perfusion parameters and advanced metabolic biomarkers2. \n \n \n The scientific foundation of the solution has been established in close collaboration with Prof. Johannes Kaesmacher, MD, at Inselspital, Bern University Hosp...